Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,022 | 66,743 | 218,779 | 172,193 | 68,590 |
| Receivables | 637,136 | 641,368 | 482,325 | 641,954 | 627,229 |
| Inventories | 414,627 | 448,294 | 457,219 | 490,768 | 512,479 |
| TOTAL | $1,185,847 | $1,267,968 | $1,286,644 | $1,431,301 | $1,347,894 |
| Non-Current Assets | |||||
| PPE Net | 508,086 | 514,414 | 544,146 | 567,498 | 569,328 |
| Intangibles | 1,973,347 | 2,012,798 | 2,081,195 | 2,143,636 | 2,175,008 |
| Other Non-Current Assets | 594,859 | 589,406 | 440,751 | 439,613 | 452,358 |
| TOTAL | $3,076,292 | $3,116,618 | $3,066,092 | $3,150,747 | $3,196,694 |
| Total Assets | $4,262,139 | $4,384,586 | $4,352,736 | $4,582,048 | $4,544,588 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21,445 | 21,445 | 21,449 | 121,694 | 21,427 |
| Accounts payable and accrued liabilities | 508,108 | 561,678 | 532,135 | 549,451 | 570,509 |
| TOTAL | $546,159 | $599,530 | $553,850 | $749,271 | $669,736 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,619,788 | 2,625,152 | 2,630,598 | 0 | 2,641,305 |
| Other Non-Current Liabilities | 318,474 | 374,738 | 294,761 | 230,076 | 282,995 |
| TOTAL | $2,966,628 | $2,985,275 | $2,902,523 | $2,917,458 | $2,935,366 |
| Total Liabilities | $3,512,787 | $3,584,805 | $3,456,373 | $3,666,729 | $3,605,102 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 299,091 | 298,834 | 298,690 | 298,567 | 298,468 |
| Common Shares | 2,991 | 2,989 | 2,987 | 2,986 | 2,985 |
| Retained earnings | -80,746 | -63,844 | -20,920 | -12,152 | -19,104 |
| Other shareholders' equity | 282,946 | 323,477 | 383,858 | 404,325 | 438,483 |
| TOTAL | $749,352 | $799,781 | $896,363 | $915,319 | $939,486 |
| Total Liabilities And Equity | $4,262,139 | $4,384,586 | $4,352,736 | $4,582,048 | $4,544,588 |